Related Experiment Video
Updated: Jan 30, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Published on: March 19, 2019
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Jessica L Dunne1, Sarah J Richardson2, Mark A Atkinson3
1JDRF, 26 Broadway, 14th Floor, New York, NY, 10004, USA. JDunne@JDRF.org.
Abstract:
In type 1 diabetes, pancreatic beta cells are destroyed by chronic autoimmune responses. The disease develops in genetically susceptible individuals, but a role for environmental factors has been postulated. Viral infections have long been considered as candidates for environmental triggers but, given the lack of evidence for an acute, widespread, cytopathic effect in the pancreas in type 1 diabetes or for a closely related temporal association of diabetes onset with such infections, a role for viruses in type 1 diabetes remains unproven. Moreover, viruses have rarely been isolated from the pancreas of individuals with type 1 diabetes, mainly (but not solely) due to the inaccessibility of the organ. Here, we review past and recent literature to evaluate the proposals that chronic, recurrent and, possibly, persistent enteroviral infections occur in pancreatic beta cells in type 1 diabetes. We also explore whether these infections may be sustained by different virus strains over time and whether multiple viral hits can occur during the natural history of type 1 diabetes. We emphasise that only a minority of beta cells appear to be infected at any given time and that enteroviruses may become replication defective, which could explain why they have been isolated from the pancreas only rarely. We argue that enteroviral infection of beta cells largely depends on the host innate and adaptive immune responses, including innate responses mounted by beta cells. Thus, we propose that viruses could play a role in type 1 diabetes on multiple levels, including in the triggering and chronic stimulation of autoimmunity and in the generation of inflammation and the promotion of beta cell dysfunction and stress, each of which might then contribute to autoimmunity, as part of a vicious circle. We conclude that studies into the effects of vaccinations and/or antiviral drugs (some of which are currently on-going) is the only means by which the role of viruses in type 1 diabetes can be finally proven or disproven.
Insights
Chronic enteroviral infections in pancreatic beta cells may trigger type 1 diabetes autoimmunity. Further research on antiviral interventions is crucial to confirm or refute the role of viruses in this autoimmune disease.
Area of Science:
- Immunology
- Virology
- Endocrinology
Background:
- Type 1 diabetes involves autoimmune destruction of pancreatic beta cells.
- Environmental factors, particularly viral infections, are suspected triggers.
- Direct evidence linking viruses to type 1 diabetes has been limited due to diagnostic challenges.
Purpose of the Study:
- To review evidence for chronic, recurrent, or persistent enteroviral infections in pancreatic beta cells in type 1 diabetes.
- To explore the potential role of different viral strains and multiple infections over time.
- To evaluate how host immune responses influence viral persistence and disease development.
Main Methods:
- Comprehensive review of existing literature on enteroviruses and type 1 diabetes.
- Analysis of proposed mechanisms for viral involvement in beta cell autoimmunity.
- Discussion of factors influencing viral detection and host immune responses.
Main Results:
- Enteroviral infections may affect a minority of beta cells and can become replication-defective, explaining rare isolations.
- Viral infections could contribute to autoimmunity by triggering inflammation, beta cell stress, and dysfunction.
- Host immune responses, including those from beta cells, play a key role in enteroviral infection dynamics.
Conclusions:
- Enteroviruses are proposed to play a multifaceted role in type 1 diabetes pathogenesis.
- Viruses may initiate and perpetuate autoimmune responses, leading to beta cell damage.
- Clinical trials of vaccinations or antiviral drugs are necessary to definitively establish or refute the role of viruses in type 1 diabetes.
Related Concept Videos
Vaccinations
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Antiviral System of Bacteria and Archaea: CRISPR

